Small Molecules
Drug Candidate | Primary Indications | Development Stage | ||
---|---|---|---|---|
Pre-Clinical | Phase 1 | Phase 2 | ||
FHL-101 | PD |
|
||
FHL-201 | AD / PD |
|
||
FHL-301 | AD / PD |
|
||
FHL-601 | PD |
|
||
FHL-101 | PD |
|
Peptides
Drug Candidate | Primary Indications | Development Stage | ||
---|---|---|---|---|
Pre-Clinical | Phase 1 | Phase 2 | ||
FHL-401 | AD / PD |
|
||
FHL-501 | AD / PD |
|